The United States Food and Drug Administration staff members have not raised new concerns over data on Moderna Inc’s coronavirus vaccine in documents made public, preparing the way for US authorisation of a second, easier-to-handle vaccine.
According to Reuters, the FDA staff said the vaccine was effective without any specific safety issues in adults over the age of 18 in the documents prepared for Thursday’s meeting of outside experts, who will discuss whether to endorse a US emergency use authorisation (EUA) for the Moderna shot.
